These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8641669)

  • 1. [Progress of research on tumor suppressor genes].
    Kuzumaki N
    Hokkaido Igaku Zasshi; 1996 Mar; 71(2):133-7. PubMed ID: 8641669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-suppressive function of mutated gelsolin in ras-transformed cells.
    Müllauer L; Fujita H; Ishizaki A; Kuzumaki N
    Oncogene; 1993 Sep; 8(9):2531-6. PubMed ID: 8395682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor suppressive function of gelsolin].
    Kuzumaki N; Tanaka M; Sakai N; Fujita H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1436-41. PubMed ID: 9309138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gelsolin: a candidate for suppressor of human bladder cancer.
    Tanaka M; Müllauer L; Ogiso Y; Fujita H; Moriya S; Furuuchi K; Harabayashi T; Shinohara N; Koyanagi T; Kuzumaki N
    Cancer Res; 1995 Aug; 55(15):3228-32. PubMed ID: 7614452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study on alterations of gene expression in a flat revertant R1 from ras-oncogene transformed NIH/3T3 cells].
    Müllauer L
    Hokkaido Igaku Zasshi; 1993 Sep; 68(5):705-16. PubMed ID: 7693563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth-inhibitory functions of a mutated gelsolin (His321) in NIH/3T3 mouse fibroblasts.
    Ishizaki A; Fujita H; Kuzumaki N
    Exp Cell Res; 1995 Apr; 217(2):448-52. PubMed ID: 7698245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functions of [His321]gelsolin isolated from a flat revertant of ras-transformed cells.
    Fujita H; Laham LE; Janmey PA; Kwiatkowski DJ; Stossel TP; Banno Y; Nozawa Y; Müllauer L; Ishizaki A; Kuzumaki N
    Eur J Biochem; 1995 May; 229(3):615-20. PubMed ID: 7758454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation.
    Mikheev AM; Mikheeva SA; Liu B; Cohen P; Zarbl H
    Carcinogenesis; 2004 Jan; 25(1):47-59. PubMed ID: 14555616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of two-dimensional gel electrophoresis in studies on the role of cytoskeletal plaque proteins as tumor suppressors.
    Ben-Ze'ev A
    Electrophoresis; 1996 Nov; 17(11):1752-63. PubMed ID: 8982608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gelsolin gene therapy by retrovirus producer cells for human bladder cancer in nude mice.
    Tanaka M; Sazawa A; Shinohara N; Kobayashi Y; Fujioka Y; Koyanagi T; Kuzumaki N
    Cancer Gene Ther; 1999; 6(5):482-7. PubMed ID: 10505859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p63: oncogene or tumor suppressor?
    Mills AA
    Curr Opin Genet Dev; 2006 Feb; 16(1):38-44. PubMed ID: 16359856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway.
    Rouault JP; Falette N; Guéhenneux F; Guillot C; Rimokh R; Wang Q; Berthet C; Moyret-Lalle C; Savatier P; Pain B; Shaw P; Berger R; Samarut J; Magaud JP; Ozturk M; Samarut C; Puisieux A
    Nat Genet; 1996 Dec; 14(4):482-6. PubMed ID: 8944033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
    Wang H; Lai B; Li J
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
    Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
    J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
    Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of tumor suppressor genes in bladder cancer.
    Cordon-Cardo C; Reuter VE
    Semin Diagn Pathol; 1997 May; 14(2):123-32. PubMed ID: 9179973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research advances on bladder cancer associated genes].
    Zhang R; Zhang JJ; He ZG; Cheng SJ; Gao YN
    Ai Zheng; 2003 Jan; 22(1):104-7. PubMed ID: 12561447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer.
    Kugoh H; Nakamoto H; Inoue J; Funaki K; Barrett JC; Oshimura M
    Mol Carcinog; 2002 Nov; 35(3):148-56. PubMed ID: 12410566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line.
    Fujimoto E; Sato H; Shirai S; Nagashima Y; Fukumoto K; Hagiwara H; Negishi E; Ueno K; Omori Y; Yamasaki H; Hagiwara K; Yano T
    Oncogene; 2005 May; 24(22):3684-90. PubMed ID: 15782139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.